MAPK/ERK signaling pathway in hepatocellular carcinoma

H Moon, SW Ro - Cancers, 2021 - mdpi.com
Simple Summary The mitogen-activated protein kinase/extracellular signal-regulated kinase
(MAPK/ERK) signaling pathway is frequently activated in liver cancer, which is one of the …

Liver regeneration: analysis of the main relevant signaling molecules

Y Tao, M Wang, E Chen, H Tang - Mediators of inflammation, 2017 - Wiley Online Library
Liver regeneration is a highly organized tissue regrowth process and is the most important
reaction of the liver to injury. The overall process of liver regeneration includes three phases …

Mechanisms of action of therapeutic antibodies for cancer

JM Redman, EM Hill, D AlDeghaither, LM Weiner - Molecular immunology, 2015 - Elsevier
The therapeutic utility of antibodies and their derivatives is achieved by various means. The
FDA has approved several targeted antibodies that disrupt signaling of various growth factor …

Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies

GJ Yoshida, A Azuma, Y Miura, A Orimo - International Journal of …, 2019 - mdpi.com
Neoplastic epithelial cells coexist in carcinomas with various non-neoplastic stromal cells,
together creating the tumor microenvironment. There is a growing interest in the cross-talk …

Modelling liver cancer microenvironment using a novel 3D culture system

A Al Hrout, K Cervantes-Gracia, R Chahwan, A Amin - Scientific reports, 2022 - nature.com
The tumor microenvironment and its contribution to tumorigenesis has been a focal highlight
in recent years. A two-way communication between the tumor and the surrounding …

[HTML][HTML] Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy

C Chen, G Wang - World journal of hepatology, 2015 - ncbi.nlm.nih.gov
The incidence and mortality of hepatocellular carcinoma (HCC) have fallen dramatically in
China and elsewhere over the past several decades. Nonetheless, HCC remains a major …

[HTML][HTML] Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question

LAM Streba, CC Vere, I Rogoveanu… - World journal of …, 2015 - ncbi.nlm.nih.gov
Non-alcoholic liver disease (NAFLD) defines liver abnormalities ranging from simple
steatosis to nonalcoholic steatohepatitis with or without cirrhosis development, occurring in …

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

F Nascimbeni, J Aron-Wisnewsky… - BMJ open …, 2016 - bmjopengastro.bmj.com
Background Type-2 diabetes mellitus (T2DM) is a risk factor for progressive non-alcoholic
fatty liver disease (NAFLD). Drugs commonly prescribed in patients with T2DM may affect …

IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages

X Wang, L Lin, B Lan, Y Wang, L Du, X Chen, Q Li… - Science …, 2020 - science.org
Metabolic traits of macrophages can be rewired by insulin-like growth factor 2 (IGF2);
however, how IGF2 modulates macrophage cellular dynamics and functionality remains …

[HTML][HTML] Diabetes mellitus and metformin in hepatocellular carcinoma

K Fujita, H Iwama, H Miyoshi, J Tani… - World journal of …, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide.
Diabetes mellitus, a risk factor for cancer, is also globally endemic. The clinical link between …